Live Breaking News & Updates on Nomix Has Expanded Its Client Base And Gained Strong Foothold In The National Sequencing Arena With Initial Outreach To International Markets Quot Dnbseq 50 Just Right Starting Scale For Small Experiments Start Up Stage Dr Grist Said

BRISBANE, Australia, Feb. 16, 2023 /PRNewswire/ GNOMIXis an Australian specialty molecular genetics laboratory and consultation service. Empowered by MGI's DNBSEQ platform, GNOMIX has been providing high-quality customised genetic services for national and international customers since 2020 including laboratory services, clinical trials, research projects, independent testing for commercialisation, food and agri-genomics, and consultancy to allied industries. Currently the clinical genomics landscape in Australia is strongly influenced by a couple of major players heavily driven by profit to provide a limited number of mainstream services. This results in the lack of availability and accessibility of technology and resources for small and medium customers, and more broadly, the stagnation of technological development. The mission of GNOMIX is to fill this gap and adapt to a wider base of customers with specific sequencing needs, budget, and timeframe. The GNOMIX laboratory located ....

South Australia , Pty Ltd , International Scientific , National Association Of Testing Authorities , National Association , Testing Authorities , Sample Preparation , Chief Scientist , Scott Grist , Flow Cells , Flow Cell Small , Flow Cell Large , Whole Genome Sequencing , Whole Exome Sequencing , Preparation System , Molecular Genetic , Feb 16 , 023 Prnewswire Gnomixis An Australian Specialty Molecular Genetics Laboratory And Consultation Service Empowered By Mgi 39s Dnbseq Platform , Nomix Has Been Providing High Quality Customised Genetic Services For National And International Customers Since 2020 Including Laboratory , Clinical Trials , Research Projects , Ndependent Testing For Commercialisation , Ood And Agri Genomics , Nd Consultancy To Allied Industries Currently The Clinical Genomics Landscape In Australia Is Strongly Influenced Bya Couple Of Major Players Heavily Driven By Profit Providea Limited Number Mainstream Services This Results Lack Availability And Accessibility Technology Resources For Small Medium Customers , Nd More Broadly , He Stagnation Of Technological Development The Mission Gnomix Is To Fill This Gap And Adapt Toa Wider Base Customers With Specific Sequencing Needs ,